Abstract:
Described are methods and compounds for diagnosis and therapy of subsets of cell proliferative disorders which are characterized by resistance to TRAIL induced apoptosis. Examples of such diseases are B-cell chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and prostate cancer. Furthermore, methods for identifying drugs which are suitable for treatment of such diseases are described.
Abstract:
Described are methods and compounds for diagnosis and therapy of subsets of cell proliferative disorders which are characterized by resistance to TRAIL induced apoptosis. Examples of such diseases are B-cell chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and prostate cancer. Furthermore, methods for identifying drugs which are suitable for treatment of such diseases are described.